NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
BIOTARGET ADVANCED REGENERATIVE THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOTARGET ADVANCED REGENERATIVE THERAPY
ST13
US500000098544299Class
44
Filing
98544299
Registration
7798757
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
05/20/2025
Trademark type
Word
Nice classes
44
Filing date
05/10/2024
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/01/2022
First use in commerce
04/01/2022
Drawing code
4
Owner type
01
Owner location
Jacksonville, FL
Examiner
MCCLELLAN, MATTHEW
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
T. M. (pessoa física)
Representatives
Andrew S. Rapacke Rapacke Law Group
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services; Medical servicesutilizing the combination of a Trigger-Point Soundwave Therapy (TPST) apparatus and class four lasers in a sequence of treatments signaling the body's production of growth factors and STEM cells and creating a biological pathway to stimulate healing at a much faster rate; Medical servicesbio-targeting advanced regenerative medicine; Medicalphysical rehabilitation and physical therapy services
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/28/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/02/2024
GNRT
NON-FINAL ACTION E-MAILED
12/02/2024
CNRT
NON-FINAL ACTION WRITTEN
12/02/2024
DOCK
ASSIGNED TO EXAMINER
11/25/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2024
NWAP
NEW APPLICATION ENTERED
05/10/2024
Continuous trademark protection
Get notified about every new filing that threatens BIOTARGET ADVANCED REGENERATIVE THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.